Scholarly Index
Elisabet E. Manasanch
GlaxoSmithKline (United States); 3,432 total citations; 237 total publications; best world rank #627
GlaxoSmithKline (United States)
3,432Total citations
237Total publications
25H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 947 | US 418 | 95.67 |
| Protein Degradation and Inhibitors | Lifetime | 933 | US 452 | 94.15 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 627 | US 291 | 91.87 |
| Chemokine receptors and signaling | 2021-2025 | 794 | US 166 | 51.61 |